logo

TRIB

Trinity Biotech·NASDAQ
--
--(--)
--
--(--)

TRIB fundamentals

Trinity Biotech (TRIB) released its earnings on May 15, 2025: revenue was 15.86M (YoY +18.09%), missed estimates; EPS was -1.2355 (YoY -72.12%), missed estimates.
Revenue / YoY
15.86M
+18.09%
EPS / YoY
-1.2355
-72.12%
Report date
May 15, 2025
Earnings Call
9:30 AM on May 23, 2025
Meeting link.

Earnings

EPS
Revenue

Revenue & Expenses

TRIB has released its 2024 Q4 earnings report, with revenue of 15.86M, reflecting a YoY change of 18.09%, and net profit of -16.95M, showing a YoY change of -208.16%. The Sankey diagram below clearly presents TRIB's revenue sources and cost distribution.

Key Indicators

Trinity Biotech (TRIB) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Trinity Biotech (TRIB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Trinity Biotech (TRIB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Trinity Biotech (TRIB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Trinity Biotech (TRIB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Trinity Biotech (TRIB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield